Lim, Tse Hui <br/><br/>
Implications of the Updated 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 Gene Testing Using Immunohistochemistry and Fluorescence In Situ Hybridization for Breast Cancer.  [electronic resource] 

 -  Archives of pathology & laboratory medicine  Feb 2016 
 - 140-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1543-2165 
<br/><br/><label>Standard No.: </label>10.5858/arpa.2015-0108-OA  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--analysis<br/>Breast Neoplasms--genetics<br/>Female<br/>Genetic Testing--methods<br/>Humans<br/>Immunohistochemistry--methods<br/>In Situ Hybridization, Fluorescence--methods<br/>Practice Guidelines as Topic<br/>Receptor, ErbB-2--analysis<br/>Reproducibility of Results<br/>Retrospective Studies